Navin Khanna

Last updated
Navin Khanna
Navin Khanna Photo jpg.jpg
NationalityFlag of India.svg  India
Alma mater University of Lucknow; All India Institute of Medical Sciences, New Delhi
Awards Padma Shri India IIIe Klasse.jpg Padma Shri
Scientific career
FieldsBiotechnology, molecular biology, and diagnostics
Institutions

Navin Khanna is an Indian researcher and scientist known for his work on diagnostic kits for viral infections, including dengue, HIV, hepatitis C (HCV), and hepatitis B (HBV). [1] In 2020, he was awarded the Padma Shri, India's fourth-highest civilian honor, for his contributions to science and engineering. [2]

Contents

Education

Navin Khanna completed his Master of Science (MSc) in Biochemistry at the University of Lucknow. He then pursued a Doctor of Philosophy (PhD) in Biochemistry from the All India Institute of Medical Sciences (AIIMS) in New Delhi. [3]

Career

Khanna began his academic career in 1983 as an Alberta Heritage Foundation Fellow at the Cell Regulation Group, University of Calgary, Alberta, Canada, where he worked until 1987. He later held a position as a Postgraduate Research Biologist at the Centre for Molecular Genetics, University of California, San Diego, from 1987 to 1989. From 1989 to 1990, Khanna served as a Research Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of California, Irvine. [3]

In 1990, Khanna joined the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, as a Senior Research Scientist. He continued his work at ICGEB, leading the Recombinant Gene Products Laboratory from 1994 until 2022. [3]

Research

Khanna led the Recombinant Gene Products laboratory at ICGEB for over 25 years, where he focused on developing genetically engineered biomolecules for medical applications. [4] [5] Khanna and his team developed the Dengue Day 1 Test kit, which became a significant advancement in early dengue diagnosis, it was developed in collaboration with J. Mitra & Co., which detects dengue infection within 15 minutes from the onset of fever. [6]

His team also contributed to the production of Hepatitis B vaccines and recombinant human insulin. [4] [5] [6]

Khanna has worked on developing a dengue vaccine, receiving support from the Indo-US Vaccine Action Program, Wellcome Trust, National Biopharma Mission, and other organizations. [6] [5]

At the International Centre for Genetic Engineering and Biotechnology (ICGEB), Khanna's team developed technologies that led to the commercialization of over 20 diagnostic kits. These include point-of-care tests for viral infections such as Dengue, HIV, Hepatitis C (HCV), and Hepatitis B (HBV). The diagnostic kits, known for their affordability and efficacy, have been utilized in several developing countries. [6] [5]

Awards and honors

Khanna received the VASVIK Industrial Research Award in Biological Science and Technology in 2007.[ citation needed ] In 2011, he was awarded the Biotech Commercialization Award by the Department of Biotechnology, Government of India.[ citation needed ] The following year, he received the Ranbaxy Research Award in Pharmaceutical Sciences from the Ranbaxy Science Foundation. In 2013, Khanna was honored with the Om Prakash Bhasin Foundation Award in Biotechnology. [7]

In 2015, he was recognized as a Fellow of the National Academy of Sciences and received the Scientist Award from the Organization of Pharmaceutical Producers of India.[ citation needed ] The following year, he was elected as a Fellow of the Indian Academy of Sciences, and in 2017, he became a Fellow of the Indian National Science Academy. Also in 2017, he was awarded the Anjani Mashelkar Inclusive Innovation Award. [7] In 2020, he was honored with the Padma Shri, India's fourth-highest civilian award, in the Science and Engineering category, in recognition of his efforts to translate laboratory research into socially beneficial products. [8]

Selected bibliography

Related Research Articles

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<i>Dengue virus</i> Species of virus

Dengue virus (DENV) is the cause of dengue fever. It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, all of which can cause the full spectrum of disease. Nevertheless, the mainstream scientific community's understanding of dengue virus may be simplistic as, rather than distinct antigenic groups, a continuum appears to exist. This same study identified 47 strains of dengue virus. Additionally, coinfection with and lack of rapid tests for Zika virus and chikungunya complicate matters in real-world infections.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

<span class="mw-page-title-main">Centre for Cellular and Molecular Biology</span> Life science research institute in Hyderabad, India

The Centre for Cellular and Molecular Biology or CCMB is an Indian fundamental life science research establishment located in Hyderabad that operates under the aegis of the Council of Scientific and Industrial Research. CCMB is a designated "Centre of Excellence" by the Global Molecular and Cell Biology Network, UNESCO.

<span class="mw-page-title-main">Hepatitis B vaccine</span> Vaccine against hepatitis B

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people, routine immunization results in more than 95% of people being protected.

A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression, in which case it is a recombinant subunit vaccine.

Chetan Eknath Chitnis is an Indian scientist in the field of malaria research. He is the head of the Malaria Parasite Biology and Vaccines Unit at the Institut Pasteur in Paris and an elected fellow of the Indian Academy of Sciences (2009) as well as Indian National Science Academy (2014). He received the Shanti Swaroop Bhatnagar Award in 2004 and the Infosys Prize in Life Sciences 2010. Chitnis is the former principal investigator of the malaria research group at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi.

GC Biopharma [Green Cross Corporation] is a biopharmaceutical company headquartered in Yongin, South Korea.

Dengue vaccine is a vaccine used to prevent dengue fever in humans. Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga.

Koduru Ishwara Varaprasad Reddy is an Indian entrepreneur and founder of vaccine manufacturing company Shantha Biotechnics. The Govt of India awarded him the Padma Bhushan award in 2005 for his contribution in the field of science and engineering. He also received an honorary doctorate from Sri Venkateshwara University, Gitam University, and Vignan University for his pioneering efforts.

Virander Singh Chauhan is an Indian scientist and a Rhodes Scholar working in the fields of genetic engineering and biotechnology. He is known for his contributions to the development of a recombinant vaccine for malaria. and for synthetic structural peptides with biological functions. He was honored by the Government of India in 2012 with the fourth highest Indian civilian award of Padma Shri. He is the present Chancellor of the Gandhi Institute of Technology and Management.

Asis Datta is an Indian biochemist, molecular biologist and genetic engineer, known for his research on genetically modified foods and food nutritional security. He was the founding Director of the National Institute of Plant Genome Research and is credited with the discovery of genes that assist in extended preservation of fruits and vegetables. He is a recipient of the Shanti Swarup Bhatnagar Award, the highest Indian award and in the Science category, and was awarded the fourth highest civilian award of the Padma Shri, by the Government of India, in 1999. In 2008, he was included again in the Republic Day Honours list for the third highest civilian honour of the Padma Bhushan.

Raman Viswanathan was an Indian chest physician, medical mycologist and pulmonologist, considered by many as the father of Chest Medicine in India. He was the founder director of Vallabhbhai Patel Chest Institute, a postgraduate medical institute based in Delhi. An elected fellow of the American College of Chest Physicians, Royal College of Physicians of London, Indian National Science Academy and the Academy of Medical Sciences, United Kingdom, he was a recipient of several honors including the Forlanini Medal by Italian Tuberculosis Association and the Eugeno Morelli Prize of the National Academy of Sciences, Italy. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1974, for his contributions to medicine.

Kallipatti Ramasamy Palaniswamy is an Indian gastroenterologist, medical academic and writer and a senior consultant at Apollo Hospital, Chennai. He is a former president (2004–05) of the Indian Society of Gastroenterology and a patron its Tamil Nadu chapter. After graduating in medicine from JJM Medical College, Davangere in 1972, he continued his studies to secure an MD in general medicine in 1977 and a DM in gastroenterology in 1981, simultaneously working as a member of faculty. In 1986, while working as an assistant professor, he was deputed to Stanley Medical College, Chennai as a professor where he established the department of gastroenterology.

Vijay Kumar is an Indian molecular biologist, virologist and an honorary scientist at the International Centre for Genetic Engineering and Biotechnology. Known for his research in hepatology, Kumar is an elected fellow of National Academy of Sciences, India, National Academy of Medical Sciences, and National Academy of Agricultural Sciences as well as a J. C. Bose National Fellow of the Department of Biotechnology. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1997.

<span class="mw-page-title-main">Shahid Jameel</span> Indian virologist and academic (born 1957)

Shahid Jameel is an Indian virologist and academic. Dr. Jameel is the Sultan Qaboos bin Said Fellow at Oxford Centre for Islamic Studies and Research Fellow, Green Templeton College, University of Oxford. He serves as the Principal Investigator for the Centre's project on Public Health, Science and Technology in Muslim societies. Previously he was the director of the Trivedi School of Biosciences since its inception in the year 2020 at Ashoka University. He was formerly head of the scientific advisory group to the Indian SARS-CoV-2 Genomics Consortia (INSACOG) established in December 2020, and the chief executive officer of Wellcome Trust DBT India Alliance. Known for his research in hepatitis E virus, Jameel is an elected fellow of all the three major Indian science academies viz. National Academy of Sciences, India, Indian Academy of Sciences, and Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2000.

Saumitra Das is an Indian microbiologist and a professor at the Department of Microbiology and Cell Biology of the Indian Institute of Science. Known for his studies in the fields of molecular virology and molecular biology, Das is an elected fellow of all the three major Indian science academies namely, the Indian Academy of Sciences, the National Academy of Sciences, India and the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2005.

Owais Mohammad is an Indian immunologist, nano-technologist and a professor at the interdisciplinary biotechnology unit of the Aligarh Muslim University. Known for his studies on nanotechnology-based vaccine and drug delivery, Owais is the author of two books, Trypanothione reductase: a potential anti-leishmanial drug target and Antimicrobial properties of clove oil: clove oils as antimicrobial agent. He has also co-edited two books, Modern Phytomedicine: Turning Medicinal Plants into Drugs and Combating Fungal Infections: Problems and Remedy, and has contributed chapters. His studies have also been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 60 of them. He is a recipient of the Rashtriya Gaurav Award of the India International Friendship Society. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007. His work has been displayed on cover pages of FEMS Immunol. Med Microbiology for all the issues of Year 2006 and Molecular Medicine in May–June issue of Year 2007.

<span class="mw-page-title-main">Scott Halstead</span> American scientist and virologist

Scott Halstead is an American physician-scientist, virologist and epidemiologist known for his work in the fields of tropical medicine and vaccine development. He is considered one of the world's foremost authorities on viruses transmitted by mosquitoes, including Dengue, Japanese encephalitis, chikungunya and Zika. He was one of the first researchers to identify the phenomenon known as antibody-dependent enhancement (ADE), where the antibodies generated from a first dengue infection can sometimes worsen the symptoms from a second infection.

References

  1. ↑ Singh, Seema (2 Jan 2017). "Meet India's Judge Dredd of Dengue". The Ken. Retrieved 23 Oct 2024.
  2. ↑ "Previous Awardees". padmaawards.gov.in. Retrieved 23 Oct 2024.
  3. 1 2 3 Karelia, Gopi (5 Feb 2020). "Priced at Rs 140, Padma Shri Awardee's Kit Can Diagnose Dengue in 15 Minutes!". The Better India. Retrieved 23 Oct 2024.
  4. 1 2 Standard, Business (19 Oct 2016). "Sun Pharma & ICGEB to jointly develop dengue vaccine". Business News, Finance News, India News, Assembly Election Results 2024, Stock Markets BSE/NSE News, SENSEX, NIFTY. Retrieved 23 Oct 2024.{{cite web}}: |first= has generic name (help)
  5. 1 2 3 4 Dhar, Shobhita (5 Feb 2017). "Botanical drugs are safe, effective and affordable: Dr Navin Khanna". The Times of India. Retrieved 23 Oct 2024.
  6. 1 2 3 4 Jyoti Singh, TV Venkatesawaran (31 Oct 2017). "Finally, antiviral drug for dengue in the offing". Down To Earth. Retrieved 23 Oct 2024.
  7. 1 2 "Navin Khanna". ICGEB. 30 Aug 2018. Retrieved 23 Oct 2024.
  8. ↑ "Dr.Navin Khanna of ICGEB selected for Padma Shri Award 2020" (PDF). vigyanprasar.gov.in. Retrieved 23 Oct 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.